v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Sep. 24, 2024
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:                    
Net loss $ (638,726) $ (2,008,476) $ (660,583) $ (538,770) $ (862,791) $ (2,647,202) $ (1,199,353) $ (654,640) $ (6,278,191) $ (1,517,431)
Adjustments to reconcile net loss to net cash used in operating activities:                    
Depreciation and amortization   75,000   150,000 150,000 300,000  
Impairment loss on Intellectual property             2,550,000  
Loss on investment             500,000  
Amortization of debt discounts         141,350 6,667  
Stock-based compensation         400,000 1,036,496 1,238,650  
Stock-based compensation loss on stock repurchased from related parties           137,500      
Shares issued for services           607,000      
Gain on debt settlement             175,000  
Changes in operating assets and liabilities:                    
Inventory, net         642 882  
Accounts receivable             354  
Prepaid expenses and other current assets         8,627 48,328 (4,891) (43,775) (79,985)  
Accounts payable         1,379 123,454 6,935 139,502 (95,101)  
Accrued expenses and other current liabilities         30,537 146,207 (11,438) 6,816 (10,180)  
Net cash used in operating activities         (272,248) (1,013,867) (451,105) (551,743) (1,692,258)  
Cash flows from investing activities:                    
Cash acquired in reverse merger         608,596      
Net cash provided by investing activities         608,596      
Cash flows from financing activities:                    
Proceeds from initial public offering             3,235,692  
Proceeds from Convertible notes             170,000  
Related party loan payable         50,000 666,232 120,000  
Repayments of related party debt             (120,000)  
Proceeds from shares         6,000 6,800  
Proceeds from PIPE financing, net           3,870,000      
Advance for repurchase of common stock           (150,000)      
Repurchase of common stock           (3,075,000)      
Net cash provided by financing activities         645,000 56,000 666,232 3,412,492  
Net decrease in cash and cash equivalents         336,348 (368,867) (395,105) 114,489 1,720,234  
Cash and cash equivalents, beginning of period   $ 2,189,232   $ 468,998 132,650 2,189,232 468,998 18,161 468,998 18,161
Cash and cash equivalents, end of period $ 1,820,365   $ 73,893   468,998 1,820,365 73,893 132,650 2,189,232 $ 468,998
Supplemental disclosure of non-cash investing and financing activities:                    
Shares sold on subscription             800  
Settlement of related party debt             78,980  
Discounts on convertible promissory notes             $ 118,017  
Common stock sold on subscription           1,600      
Share issued for common stock payable           60,000      
Share issued for debt conversion           350,367      
Accretion of Series A preferred stock to redemption value           2,062,360      
Dividends accrued on Series A Convertible Preferred Stock           $ 88,508